TP53 and colorectal carcinoma: These two works highlighted the significant diagnostic ability of autoantibodies against different p53, p63, and p73 proteoforms, which was higher than that of CEA and autoantibodies against the canonical p53 protein, for both CRC patients and individuals with premalignant lesions, suggesting a potential role of these autoantibodies for the early detection of the disease.